I see where your coming from I can post only what I read from people who know more than me … The principle point here is 1) FDA narrowly passed Srp901 because of the Boys parents ( did not reach endpoints) 2) Pfizer cancelled their Phase 3 trial because they failed to reach their endpoints.. 3) FDA has approved srp901 because Roche is working on gene therapy and putting $$ millions into the research 4) We are looking at single digit boys using Srp901 5) Exon skipping drugs are not allowed in Europe for DMD 6)Cost related to SRP901.. rebate from US health funds reluctant to fund a drug that shows no efficacy ..
All in all Ay least I post what I read and watch re videos… but at the end of theday this decision has no bearing on Per..
We continue $$
PER Price at posting:
8.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)